BioLife Solutions (BLFS) Getting Somewhat Positive News Coverage, Study Finds

News headlines about BioLife Solutions (NASDAQ:BLFS) have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BioLife Solutions earned a news sentiment score of 0.10 on Accern’s scale. Accern also assigned headlines about the medical equipment provider an impact score of 44.3067042196406 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Separately, Maxim Group raised shares of BioLife Solutions to a “buy” rating and set a $8.00 target price for the company in a research note on Thursday, November 30th.

BioLife Solutions (BLFS) traded down $0.11 during trading hours on Thursday, hitting $5.85. 103,100 shares of the company traded hands, compared to its average volume of 71,650. BioLife Solutions has a twelve month low of $1.62 and a twelve month high of $7.53. The company has a market capitalization of $78.92, a PE ratio of -13.93 and a beta of 0.27.

BioLife Solutions (NASDAQ:BLFS) last released its quarterly earnings data on Thursday, November 9th. The medical equipment provider reported ($0.03) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.03. BioLife Solutions had a negative net margin of 52.10% and a negative return on equity of 49.92%. The firm had revenue of $2.96 million during the quarter, compared to analysts’ expectations of $2.60 million. analysts anticipate that BioLife Solutions will post -0.23 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “BioLife Solutions (BLFS) Getting Somewhat Positive News Coverage, Study Finds” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Insider Buying and Selling by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with's FREE daily email newsletter.

Leave a Reply